Ionis Pharmaceuticals, Inc(NASDAQ:IONS) 
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis...
Website: http://www.ionispharma.com
Founded: 1989
Full Time Employees: 817
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 28.10
H 28.50
L 26.88
C 27.09
V 2,292,741
10EMA 27.09
20EMA 27.09
60EMA 27.09
120EMA 27.09
250EMA 27.09